Javier Narbona

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Transforming Growth Factor

Saccharomyces Cerevisiae

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Javier Narbona, Rubén G Gordo, Jaime Tome-Amat, Javier Lacadena
A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin. Cancers 15 (4) (2023)
Javier Narbona, Rubén G Gordo, Jaime Tome-Amat, Javier Lacadena
A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin. Cancers 15 (4) (2023)
Javier Narbona, Luisa Hernández-Baraza, Rubén G Gordo, Laura Sanz, Javier Lacadena
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment. Biomolecules 13 (7) (2023)
Javier Narbona, Rubén G Gordo, Jaime Tome-Amat, Javier Lacadena
A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin. Cancers 15 (4) (2023)